Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. We produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world's most closely watched drugs. In this organization, the editors have complete authority to call the news as they see it.